Vashon, WA, United States of America

Marc A Gavin

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 105(Granted Patents)


Location History:

  • Vashon, WA (US) (2016 - 2023)
  • Seattle, WA (US) (2020 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Unveiling the Inventive Mind of Marc A Gavin

Introduction:

Meet Marc A Gavin, a visionary inventor hailing from Vashon, WA (US), whose innovative spirit has led to the creation of 8 groundbreaking patents. His work at Amgen Inc. has reshaped the landscape of autoimmune disorder treatment with cutting-edge methodologies.

Latest Patents:

Marc's latest patents showcase his expertise in the field of immunosuppressive molecules and T-regulatory cell proliferation. One notable patent focuses on the use of IL-2 variants to treat inflammatory and autoimmune disorders, while another patent introduces IL-2 muteins for the expansion and activation of T-regulatory cells on a large scale.

Career Highlights:

With a keen focus on advancing healthcare solutions, Marc A Gavin has made significant contributions to the biopharmaceutical industry through his patent portfolio. His dedication to innovation and scientific excellence has positioned him as a key player in the development of novel therapeutic approaches.

Collaborations:

In his journey towards inventing cutting-edge solutions, Marc has collaborated with esteemed colleagues such as Li Li and Gunasekaran Kannan. Together, they have brought forth a fusion of diverse expertise to enhance the efficacy of immunosuppressive treatments.

Conclusion:

Marc A Gavin's inventive spirit and dedication to revolutionizing autoimmune disorder treatment through patentable solutions have left a lasting impact on the industry. His collaborations and career highlights serve as a testament to his commitment to advancing healthcare innovations for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…